Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-01 5:32 pm Purchase | 2026-03-25 | 13G | VERA THERAPEUTICS INC VERA | Point72 Asset Management, L.P. | 1,229,525 1.700% | 1,229,525 (New Position) | Filing History |
| 2026-03-27 1:50 pm Sale | 2026-03-13 | 13G | VERA THERAPEUTICS INC VERA | VANGUARD GROUP INC | 0 0.000% | -3,570,401 (Position Closed) | Filing History |
| 2026-03-11 4:05 pm Purchase | 2026-03-04 | 13G | VERA THERAPEUTICS INC VERA | Deep Track Capital LP | 3,921,362 5.500% | 3,921,362 (New Position) | Filing History |
| 2026-03-05 06:11 am Purchase | 2025-12-10 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,847,837 4.000% | 34,000 (+1.21%) | Filing History |
| 2026-02-17 10:26 am Purchase | 2025-12-31 | 13G | VERA THERAPEUTICS INC VERA | PRICE T ROWE ASSOCIATES INC | 5,461,988 7.700% | 1,795,390 (+48.97%) | Filing History |
| 2026-02-05 1:40 pm Purchase | 2025-12-31 | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 2,885,853 4.100% | 100,569 (+3.61%) | Filing History |
| 2026-01-30 2:43 pm Purchase | 2025-12-31 | 13G | VERA THERAPEUTICS INC VERA | VANGUARD GROUP INC | 3,570,401 5.030% | 3,570,401 (New Position) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | VERA THERAPEUTICS INC VERA | PRICE T ROWE ASSOCIATES INC | 3,666,598 5.700% | -272,511 (-6.92%) | Filing History |
| 2025-08-14 11:00 am Purchase | 2025-06-30 | 13G | VERA THERAPEUTICS INC VERA | Kynam Capital Management LP | 3,426,887 5.370% | 1,850,338 (+117.37%) | Filing History |
| 2025-06-11 5:38 pm Purchase | 2025-06-06 | 13G | VERA THERAPEUTICS INC VERA | James E. Flynn | 3,348,117 5.250% | 3,348,117 (New Position) | Filing History |
| 2025-02-14 09:30 am Purchase | 2024-12-31 | 13G | VERA THERAPEUTICS INC VERA | Avoro Capital Advisors LLC | 5,610,000 8.900% | 1,300,410 (+30.17%) | Filing History |
| 2024-11-14 4:10 pm Sale | 2024-09-30 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 2,475,000 4.500% | -1,425,000 (-36.54%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-02-29 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 3,900,000 7.300% | -1,550,000 (-28.44%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | VERA THERAPEUTICS INC VERA | PRICE T ROWE ASSOCIATES INC | 3,939,109 7.200% | 3,939,109 (New Position) | Filing History |
| 2024-11-14 12:15 pm Sale | 2024-09-30 | 13G | VERA THERAPEUTICS INC VERA | Kynam Capital Management LP | 1,576,549 2.490% | -2,073,790 (-56.81%) | Filing History |
| 2024-11-14 09:35 am Purchase | 2024-09-30 | 13G | VERA THERAPEUTICS INC VERA | Avoro Capital Advisors LLC | 4,309,590 7.900% | 4,309,590 (New Position) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 2,785,284 5.080% | 10,912 (+0.39%) | Filing History |
| 2024-11-04 7:49 pm Purchase | 2024-10-31 | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV, LLC | 5,184,062 8.400% | 20,000 (+0.39%) | Filing History |
| 2024-03-26 7:57 pm Sale | 2024-03-22 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,813,837 5.400% | -834,459 (-22.87%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2024-01-30 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,648,296 6.900% | 171,215 (+4.92%) | Filing History |